Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy -- patients' views of early cessation of therapy.

Abstract

BACKGROUND Current therapy for chronic hepatitis C infection involves a course of pegylated interferon and ribavirin. Patients who do not show a virological response after 12 weeks of therapy have a low probability of sustained virological response and it is therefore recommended that such patients stop treatment. AIM To assess patients' views of early… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.